Pictet Asset Management (Switzerland)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$5.73M Buy
61,069
+1,467
+2% +$114K 0.01% 743
2023
Q1
$4.04M Buy
59,602
+1,487
+3% +$95.6K 0.01% 821
2022
Q4
$2.88M Sell
58,115
-771
-1% -$31.5K ﹤0.01% 864
2022
Q3
$1.91M Buy
58,886
+1,378
+2% +$56.8K ﹤0.01% 934
2022
Q2
$2.27M Hold
57,508
﹤0.01% 927
2022
Q1
$4.02M Hold
57,508
﹤0.01% 853
2021
Q4
$4.48M Sell
57,508
-153
-0.3% -$13.5K ﹤0.01% 857
2021
Q3
$5.5M Buy
+57,661
New +$6.09M 0.01% 817

Other funds holding EXAS

Pictet Asset Management (Switzerland)'s EXAS Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Exact Sciences (EXAS) stake by 2.5% in Q2 2023, buying an estimated $114K and bringing the position to 61,069 shares worth $5.73M. The position accounts for 0.01% of the portfolio, ranked #743.

Pictet Asset Management (Switzerland) first reported a position in EXAS in Q3 2021 and has held it in 8 quarters since. 654 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 61,069 shares of Exact Sciences worth $5.73M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 1,467 Exact Sciences shares in Q2 2023, an estimated $114K.
  • Exact Sciences made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #743 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Exact Sciences in Q3 2021 and has held it in 8 quarters since.
  • 654 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.